Prostate cancer study tracks immune changes during brachytherapy
NCT ID NCT07131956
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at how the immune system changes in men with prostate cancer who receive brachytherapy (internal radiation). Researchers will collect blood and tissue samples before, during, and after treatment to track immune cells and DNA. The goal is to better understand the body's response to radiation, not to test a new drug. About 200 participants will be enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal how brachytherapy affects the immune system, potentially guiding future combination treatments for prostate cancer.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve outcomes for participants and may not lead to any new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Klinik für Strahlentherapie
NOT_YET_RECRUITINGAugsburg, Bavaria, 86156, Germany
-
Klinik und Poliklinik für Strahlentherapie und Radioonkologie
NOT_YET_RECRUITINGMunich, Bavaria, 81377, Germany
-
Strahlenklinik Erlangen
RECRUITINGErlangen, Bavaria, 91054, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A sharper eye on prostate cancer return: PSMA PET vs. MRI
- AI may help spot dangerous prostate cancer and spare men from needless biopsies
- Blood test may spot prostate cancer without a needle
- Sharper radiation beam aims to hit High-Risk prostate cancer harder, spare healthy tissue
- AI reads scans to spot prostate cancer, spare unnecessary biopsies
- Prostate cancer disparities: uncovering the hidden drivers